Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.

Xu, Chuan et al.·Viruses·2021·
RPEP-058902021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

HNP1, HD5, and RC101 inhibited SARS-CoV-2 entry, while HNP4 and HD6 showed weak activity.

Key Numbers

How They Did This

The study tested the antiviral effects of various human defensins on pseudotyped and replication-competent SARS-CoV-2 viruses.

Why This Research Matters

Understanding how human defensins work against SARS-CoV-2 could lead to new therapeutic strategies for COVID-19. This research highlights the potential of innate immune factors in combating viral infections.

What This Study Doesn't Tell Us

The study primarily focused on in vitro models, which may not fully replicate human responses to infection.

Trust & Context

Original Title:
Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.
Published In:
Viruses, 13(7) (2021)
Database ID:
RPEP-05890

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-05890·https://rethinkpeptides.com/research/RPEP-05890

APA

Xu, Chuan; Wang, Annie; Marin, Mariana; Honnen, William; Ramasamy, Santhamani; Porter, Edith; Subbian, Selvakumar; Pinter, Abraham; Melikyan, Gregory B; Lu, Wuyuan; Chang, Theresa L. (2021). Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.. Viruses, 13(7). https://doi.org/10.3390/v13071246

MLA

Xu, Chuan, et al. "Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.." Viruses, 2021. https://doi.org/10.3390/v13071246

RethinkPeptides

RethinkPeptides Research Database. "Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Vir..." RPEP-05890. Retrieved from https://rethinkpeptides.com/research/xu-2021-human-defensins-inhibit-sarscov2

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.